Dr. Yulia Sapir-Lekhovitser

Chief Science Officer

Prior to joining FesariusTherapeutics, from January 2016 to July 2017, Dr. Sapir-Lekhovitser was a Research Scientist at Cresilon Inc., a NYC-based developer and manufacturer of a next generation surgical hemostat.  As Cresilon’s most senior scientist, she led research activities in R&D operations, driving Cresilon’s investigation and product development in rheology and polymer science. She also played a significant role in the research management and technology transfer efforts, serving as subject matter expert in collaborating with the quality control, quality assurance, manufacturing and regulatory affairs departments.

Prior to joining Cresilon, from 2009 until August 2015, she was a doctoral student at Ben-Gurion University of the Negev, Beer Sheva, Israel, where she studied at the School of Biotechnology Engineering, supervised by Professor Smadar Cohen.  For her thesis, she designed and developed novel composite biomaterials for mammalian cell cultivation and for stimulation within magnetic fields.  Additionally, she designed a novel technique utilizing an atomic force microscope that enabled movement measurements of scaffolds within a magnetic field on 3-dimesional magnetic samples.  Over a 14-month period between 2009-2012, she was a visiting researcher at Drexel University College of Medicine in Philadelphia, Pennsylvania, where she was supervised by Dr. Boris Polyak. Dr. Sapir-Lekhovitser has authored 8 peer-reviewed publications, including 2 book chapters, and a book related to biomaterials and their use in tissue engineering.